Koutentakis, M.; Kuciński, J.; Świeczkowski, D.; Surma, S.; Filipiak, K.J.; Gąsecka, A.
The Ketogenic Effect of SGLT-2 Inhibitors—Beneficial or Harmful? J. Cardiovasc. Dev. Dis. 2023, 10, 465.
https://doi.org/10.3390/jcdd10110465
AMA Style
Koutentakis M, Kuciński J, Świeczkowski D, Surma S, Filipiak KJ, Gąsecka A.
The Ketogenic Effect of SGLT-2 Inhibitors—Beneficial or Harmful? Journal of Cardiovascular Development and Disease. 2023; 10(11):465.
https://doi.org/10.3390/jcdd10110465
Chicago/Turabian Style
Koutentakis, Michail, Jakub Kuciński, Damian Świeczkowski, Stanisław Surma, Krzysztof J. Filipiak, and Aleksandra Gąsecka.
2023. "The Ketogenic Effect of SGLT-2 Inhibitors—Beneficial or Harmful?" Journal of Cardiovascular Development and Disease 10, no. 11: 465.
https://doi.org/10.3390/jcdd10110465
APA Style
Koutentakis, M., Kuciński, J., Świeczkowski, D., Surma, S., Filipiak, K. J., & Gąsecka, A.
(2023). The Ketogenic Effect of SGLT-2 Inhibitors—Beneficial or Harmful? Journal of Cardiovascular Development and Disease, 10(11), 465.
https://doi.org/10.3390/jcdd10110465